Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bone mineral density as an individual prognostic biomarker in NSCLC patients treated with immune checkpoint inhibitors

18 Apr 2024

Abstract excerpt

Background Immune checkpoint inhibitors (ICIs) have left a deep impression in the treatment of non-small cell lung cancer (NSCLC), however, not all patients benefit from it. The purpose of this study was to investigate the prognostic value of baseline bone mineral density (BMD) derived from chest computed tomography (CT) scans in NSCLC patients treated with ICIs. Methods This study included patients with advanced...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers in Disease Mechanisms
Share to Cancer Immunotherapy and Biomarkers
Share to Radiomics and Machine Learning in Medical Imaging

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38698843
DOI: 10.3389/fimmu.2024.1332303

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bone mineral density as an individual prognostic biomarker in NSCLC patients treated with immune checkpoint inhibitorsPMID 38698843Read ↗

A Novel Prognostic Scoring System Based on F-18 FDG PET/CT Volumetric Parameters, Sarcopenia, and Clinical Variables in Patients Receiving Immunotherapy for Advanced Solid Tumors: The Immunotherapy Prognostic Score (IPS)Semantic proximity Read ↗

Utility of Molecular Markers in Predicting Local Control Specific to Lung Cancer Spine Metastases Treated with Stereotactic Body RadiotherapySemantic proximity Read ↗

Assessing EGFR-mutated NSCLC with bone metastasis: Clinical features and optimal treatment strategy.Semantic proximity Read ↗

[Impact of bone metastasis on the prognosis of lung adenocarcinoma patients treated with third-generation EGFR-TKI and the underlying mechanisms].Semantic proximity Read ↗

Host-Derived Immunometabolic Biomarkers Identify Prognostic Profiles under Immunotherapy in Advanced NSCLC: the SARC-LUNG StudySemantic proximity Read ↗

Obesity, Sarcopenia, and Outcomes in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors and Tyrosine Kinase InhibitorsSemantic proximity Read ↗

Characterization of pretreatment cachexia through cytokine and nutritional analysis in lung cancer: the Marató cohortSemantic proximity Read ↗

A scoping review evaluating physical and cognitive functional outcomes in cancer survivors treated with chemotherapy: charting progress since the 2018 NCI think tank on cancer and aging phenotypes.Semantic proximity Read ↗

Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trialsSemantic proximity Read ↗

Development and Validation of a Clinically Useful Nomogram for Predicting Sarcopenia in Bone Tumor PatientsSemantic proximity Read ↗

Machine Learning Algorithm Guiding Local Treatment Decisions For Lung Cancer Patients With Bone MetastasesSemantic proximity Read ↗

Impact of frequent whole-body CT scans during immune checkpoint inhibitor (ICI) therapy on antitumor immune efficacySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.